Filing Details

Accession Number:
0001127602-11-030295
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-21 17:50:36
Reporting Period:
2011-11-18
Filing Date:
2011-11-21
Accepted Time:
2011-11-21 17:50:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1014739 Bioscrip Inc. BIOS Retail-Drug Stores And Proprietary Stores (5912) 050489664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193146 A Stuart Samuels 100 Clearbrook Road
Elmsford NY 10523
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.0001 Par Value Acquisiton 2011-11-18 11,200 $4.23 47,700 No 4 M Direct
Common Stock, $.0001 Par Value Disposition 2011-11-18 11,200 $5.49 36,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.0001 Par Value Director Stock Option Disposition 2011-11-18 11,200 $0.00 11,200 $4.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-11-27 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock, $.0001 Par Value Director Stock Option $6.14 2010-11-13 33,600 33,600 Direct
Common Stock, $.0001 Par Value Director Stock Option $4.43 2012-11-20 11,200 11,200 Direct
Common Stock, $.0001 Par Value Director Stock Option $7.96 2013-11-19 11,200 11,200 Direct
Common Stock, $.0001 Par Value Director Stock Option $6.61 2006-03-12 2015-03-12 20,000 20,000 Direct
Common Stock, $.0001 Par Value Option To Purchase Common Stock $5.33 2007-05-23 2016-05-23 5,000 5,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2010-11-13 33,600 33,600 Direct
2012-11-20 11,200 11,200 Direct
2013-11-19 11,200 11,200 Direct
2015-03-12 20,000 20,000 Direct
2016-05-23 5,000 5,000 Direct
Footnotes
  1. Fully Vested
  2. Fully Vested.
  3. These sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2011.
  4. Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.